Pharmaceuticals news continually updated from thousands of sources around the net.
Trending on the Topix Network
As a next step in a series of corporate governance modifications, McKesson Corp. said that its Board of Directors has elected N. Anthony Coles, M.D., as a new independent director, effective April 29. In connection with Dr. Coles' election, the size of the Board of Directors was increased from nine to ten members, nine of whom are independent, the ... (more)
Yes, this is a scary headline. Almost sounds sensational. It isn't. It is a cold hard fact.
Mylan COO Harry Korman sold 31,970 shares of the company's stock on the open market in a transaction dated Thursday, March 6th.
Lannett Company reached a new 52-week high during trading on Thursday , Analyst Ratings Network.com reports.
They moved to the right of conservative talk show host Hoppy Kercheval. And they moved to the right of the state police.
Achillion Pharmaceuticals released its earnings data on Friday. The company reported earnings per share for the quarter, beating the analysts' consensus estimate of by $0.02, AnalystRatingsNetwork reports.
McKesson Pharmacy Systems & Automation announced today that EnterpriseRx - its cloud-based, centrally hosted pharmacy management system - earned top honors as a Category Leader in the 2013 Best in KLAS: Software and Services report.
Together with the Danish Ministry of Environment, Novo Nordisk has released the pharmaceutical industry's first Environmental Profit and Loss account identifying the costs and areas for reduction related to water consumption, GHG emissions and air pollution.
As research becomes increasingly specialized, pharmaceutical companies many not have exactly the right expertise in house to push a project forward.
More than 20% of Americans regularly consume prescribed drugs related to mental health issues, earning contemporary America the nickname, "the Prozac Generation."
Bristol-Myers Squibb is to close its manufacturing facility in Cruiserath, Co Dublin, by the end of 2015 with the loss of 130 jobs.
Shares of Teva Pharmaceutical Industries opened at 49.80 on Thursday. Teva Pharmaceutical Industries has a one year low of $36.26 and a one year high of $50.70.
Based on its current expectations, Patheon anticipates the following results for its first-quarter ended Because Patheon's results of operations for the first quarter of fiscal 2014 have not yet been finalized, the preliminary results included in this press release are subject to change as a result of the period-end closing process and review of ... (more)
Bristol-Myers Squibb Co.' s experimental HIV drug controlled the virus as well as the company's older treatment Reyataz in a study that suggests the medicine may help difficult-to-treat patients.